CSIMarket Company Name, Ticker, Customers, else..
 

Healthcare Sector

Major Pharmaceutical Preparations Industry Growth  


Growth Rates by Company within Major Pharmaceutical Preparations Industry

New: More Major Pharmaceutical Preparations Industrys' historic revenue growth >>

 Revenue Growth Net Income Growth
Company Quarter Y / Y Sequential Y / Y Sequential
Aadi Bioscience Inc 3Q 2022 - up 23.51 % - -
Abbvie Inc 3Q 2024 up 3.83 % down -0.01 % down -12.18 % up 13.91 %
Abcellera Biologics Inc 3Q 2022 up 1740.65 % up 120.8 % - -
Abeona Therapeutics Inc 3Q 2024 up 100.51 % down -0.17 % - -
American Bio Medica Corporation 1Q 2023 down-53.28 % down -2.38 % - -
Abbott Laboratories 3Q 2022 down-4.74 % down -7.52 % down -31.67 % down -28.89 %
Arbutus Biopharma Corp 1Q 2023 down-46.85 % up 7.08 % - -
Abvc Biopharma Inc 2Q 2022 up 895.07 % up 1119.25 % - -
Abivax Sa 4Q 2023 - - - -
Acadia Pharmaceuticals Inc 3Q 2022 down-0.68 % down -2.86 % - -
Acer Therapeutics Inc 3Q 2021 - - - -
Adicet Bio Inc 3Q 2024 - - - -
Ac Immune Sa 4Q 2023 - - - -
Aclaris Therapeutics Inc 3Q 2024 down-53.18 % up 57.12 % - -
Acrivon Therapeutics Inc 3Q 2023 - - - -
Acasti Pharma Inc 1Q 2023 - - - -
Actuate Therapeutics Inc 3Q 2024 - - - -
Accustem Sciences Inc 3Q 2024 - - - -
Acurx Pharmaceuticals inc 3Q 2022 - - - -
Adagene Inc 4Q 2023 up 94.9 % up 94.9 % - -
Adc Therapeutics Sa 3Q 2024 down-91.2 % up 6.05 % - -
Adial Pharmaceuticals Inc 2Q 2022 - - - -
Aditxt Inc 1Q 2023 up 3.87 % up 17.68 % - -
Addex Therapeutics Ltd 4Q 2023 up 13.39 % up 13.39 % - -
Ayala Pharmaceuticals Inc 3Q 2022 - - - -
Aeon Biopharma inc 2Q 2022 - - - down -32.68 %
Aeterna Zentaris Inc 4Q 2023 down-20.25 % down -20.25 % - -
Kaya Holdings Inc 3Q 2024 down-94.92 % - - -
Affimed N v 4Q 2023 down-79.99 % down -79.99 % - -
Agios Pharmaceuticals Inc 2Q 2024 up 28.35 % up 5.2 % - -
Agile Therapeutics Inc 2Q 2022 up 79.41 % up 20.73 % - -
Ainos Inc 3Q 2022 up 384.17 % up 176.11 % - -
Akebia Therapeutics Inc 3Q 2022 up 0.43 % down -61.37 % - -
Akero Therapeutics Inc 3Q 2022 - - - -
Akari Therapeutics Plc 3Q 2024 - - - -
Aldeyra Therapeutics Inc 3Q 2023 - - - -
Alimera Sciences Inc 4Q 2023 up 89.98 % up 17.9 % - -
Alkermes Plc 3Q 2022 down-14.21 % down -8.64 % - -
Allakos Inc 1Q 2024 - - - -
Allarity Therapeutics Inc 2Q 2022 - - - -
Alnylam Pharmaceuticals Inc 3Q 2022 up 40.86 % up 17.56 % - -
Alpine Immune Sciences Inc 1Q 2022 up 317.17 % up 208.63 % - -
Aileron Therapeutics Inc 2Q 2022 - - - -
Altimmune inc 3Q 2022 down-98.82 % down -99.4 % - -
Alt5 Sigma Corporation 3Q 2024 - up 107.86 % - -
Alx Oncology Holdings Inc 3Q 2022 - - - -
Alzamend Neuro Inc 3Q 2024 - - - -
Amylyx Pharmaceuticals Inc 3Q 2024 down-99.59 % - - -
Ampio Pharmaceuticals inc 4Q 2021 - - - -
Amphastar Pharmaceuticals Inc 2Q 2022 up 21.45 % up 2.57 % up 101.18 % down -28.48 %
Amarin Corp Plcuk 3Q 2022 down-55.74 % down -33.44 % - -
Amneal Pharmaceuticals Inc 3Q 2024 up 17.12 % up 6.45 % down -60.39 % -
Applied Molecular Transport Inc 3Q 2023 - - - -
Anaptysbio inc 3Q 2024 up 804.67 % up 173.6 % - -
Anebulo Pharmaceuticals Inc 3Q 2024 - - - -
Ani Pharmaceuticals Inc 3Q 2023 up 57.27 % up 13.11 % - up 59.17 %
Anixa Biosciences Inc 2Q 2024 - - - -
Adlai Nortye Ltd 4Q 2023 - - - -
Annexon Inc 3Q 2023 - - - -
Alto Neuroscience Inc 3Q 2024 - - - -
An2 Therapeutics Inc 2Q 2023 - - - -
Annovis Bio Inc 3Q 2022 - - - -
Apexigen Inc 2Q 2023 - - - -
Apellis Pharmaceuticals Inc 3Q 2024 up 78.29 % down -1.43 % - -
Applied Therapeutics Inc 1Q 2024 down-98.22 % - - -
Aptorum Group Limited 4Q 2023 - - - -
Aprea Therapeutics Inc 3Q 2022 - - - -
Aptinyx Inc 1Q 2023 - - - -
Aptevo Therapeutics Inc 3Q 2022 - - - -
Aquestive Therapeutics Inc 3Q 2022 down-13.73 % down -13.58 % - -
Aravive Inc 3Q 2021 - down -36.34 % - -
Arcturus Therapeutics Holdings Inc 3Q 2024 down-7.68 % down -16.42 % - -
Ardelyx inc 3Q 2024 up 74.21 % up 34.17 % - -
Arcutis Biotherapeutics Inc 3Q 2022 - - - -
Artelo Biosciences Inc 3Q 2024 - - - -
Arvinas Inc 3Q 2024 up 195.95 % up 33.86 % - -
Arrowhead Pharmaceuticals Inc 3Q 2024 - - - -
Assembly Biosciences Inc 3Q 2024 - down -19.78 % - -
Assertio Holdings inc 3Q 2024 down-18.03 % down -6.17 % - -
Atai Life Sciences N v 2Q 2024 up 58.72 % - - -
Alterity Therapeutics Limited 2Q 2023 - - - -
Athersys Inc 3Q 2023 - - - -
180 Life Sciences Corp 2Q 2022 - - - up 87.97 %
Actinium Pharmaceuticals Inc 1Q 2022 up 51.13 % up 3986.96 % - -
Atossa Therapeutics Inc 2Q 2022 - - - -
Adhera Therapeutics Inc 1Q 2023 - - - -
Avenue Therapeutics Inc 3Q 2024 - - - -
Astria Therapeutics Inc 3Q 2022 - - - -
Aurinia Pharmaceuticals Inc 3Q 2022 up 280.3 % up 97.86 % - -
Arrivent Biopharma inc 3Q 2024 - - - -
Avadel Pharmaceuticals Plc 3Q 2024 up 3233.56 % up 22.48 % - -
Atea Pharmaceuticals Inc 2Q 2024 - - - -
Avenir Wellness Solutions Inc 2Q 2024 down-70.47 % down -34.77 % - -
Avalo Therapeutics Inc 3Q 2022 up 1007.33 % up 1347.14 % - -
Axim Biotechnologies Inc 2Q 2024 up 76.04 % down -67.01 % - -
Axsome Therapeutics Inc 2Q 2024 up 86.65 % up 16.22 % - -
Aytu Biopharma Inc 3Q 2022 up 26.3 % up 0.75 % - -
Astrazeneca Plc 4Q 2023 up 3.29 % up 3.29 % up 81.02 % up 81.02 %
Azitra Inc 3Q 2024 - - - -
Bridgebio Pharma Inc 3Q 2024 down-33.22 % up 26.01 % - -
Bicara Therapeutics Inc 3Q 2024 - - - -
Atreca inc 3Q 2021 - - - -
Briacell Therapeutics Corp 3Q 2023 - - - -
Bicycle Therapeutics Plc 3Q 2024 down-50 % down -71.41 % - -
Bioadaptives Inc 3Q 2022 down-37.53 % down -22.79 % - -
Biodexa Pharmaceuticals Plc 4Q 2023 down-45.49 % down -45.49 % - -
Bullfrog Ai Holdings Inc 3Q 2024 - - - -
Biofrontera Inc 3Q 2024 down-6.13 % up 40.05 % - -
Beigene Ltd 1Q 2024 up 67.65 % up 18.51 % - -
Bausch Health Companies Inc 3Q 2024 up 12.15 % up 4.45 % - -
Biohaven Ltd 2Q 2022 up 131.43 % down -32.55 % - -
Bioage Labs Inc 3Q 2024 - - - -
Biora Therapeutics Inc 3Q 2024 up 1500 % down -89.94 % - -
Biovie Inc 3Q 2022 - - - -
Bioxytran Inc 3Q 2022 - - - -
Bellicum Pharmaceuticals Inc 3Q 2022 down-79.8 % up 7676.92 % - -
Bellerophon Therapeutics inc 3Q 2021 - - - -
Biolinerx Ltd 4Q 2023 - - - -
Belite Bio Inc 4Q 2023 - - - -
Biomea Fusion Inc 3Q 2022 - - - -
Biomarin Pharmaceutical Inc 3Q 2022 up 23.63 % down -5.33 % - -
Bristol myers Squibb Company 3Q 2022 down-3.49 % down -5.63 % up 3.61 % up 12.53 %
Bionomics Limited 3Q 2024 - - - -
Benitec Biopharma Inc 3Q 2023 - - - -
Boundless Bio Inc 3Q 2024 - - - -
Bolt Biotherapeutics Inc 3Q 2024 down-54.87 % down -10.51 % - -
Blueprint Medicines Corporation 2Q 2023 up 55.7 % up 0.18 % - -
Bio path Holdings inc 3Q 2022 - - - -
Biophytis Sa 4Q 2023 - - - -
Barinthus Biotherapeutics Plc 3Q 2024 up 4381.74 % - - -
Bespoke Extracts Inc 3Q 2024 up 47.4 % down -0.25 % - -
Bioxcel Therapeutics Inc 3Q 2024 down-37.24 % down -80.62 % - -
Biostax Corp 2Q 2023 - - - -
Blue Water Vaccines Inc 3Q 2024 - down -42.28 % - -
Baudax Bio Inc 3Q 2023 - - - -
Calcimedica Inc 3Q 2022 - - - -
Calliditas Therapeutics Ab 4Q 2023 up 49.74 % up 49.74 % - -
Camp4 Therapeutics Corp 3Q 2024 - - - -
Capricor Therapeutics inc 3Q 2022 - - - -
Cara Therapeutics inc 3Q 2022 - down -52.99 % - -
Carisma Therapeutics Inc 3Q 2022 - - - up 427.92 %
Casi Pharmaceuticals inc 4Q 2021 up 89.92 % up 12.89 % - -
Cymabay Therapeutics Inc 4Q 2023 - - - -
Avid Bioservices Inc 3Q 2022 up 33.12 % down -5.27 % - -
Conduit Pharmaceuticals Inc 3Q 2022 - - - -
Celularity Inc 3Q 2024 up 145.54 % down -23.24 % - -
Cerevel Therapeutics Holdings Inc 1Q 2023 - - - -
Contrafect Corporation 3Q 2021 - - - -
China Health Industries Holdings Inc 1Q 2022 down-100 % down -50 % - -
Cingulate Inc 2Q 2024 - - - -
Checkpoint Therapeutics inc 3Q 2022 up 65.52 % up 166.67 % - -
Cell Source Inc 2Q 2022 - - - -
Clene Inc 3Q 2024 down-19.44 % down -4.4 % - -
Cellectar Biosciences Inc 3Q 2024 - - - -
Clearside Biomedical Inc 3Q 2022 down-91.35 % down -30.73 % - -
Clever Leaves Holdings Inc 4Q 2021 - - - up 700.1 %
Climb Bio Inc 3Q 2024 - - - -
Chemomab Therapeutics Ltd 4Q 2022 - - up 64.26 % up 2.38 %
Clearmind Medicine Inc 1Q 2017 - - - -
Compass Pathways Plc 3Q 2022 - - - -
Comera Life Sciences Holdings Inc 1Q 2023 - up 56.26 % - -
Chimerix inc 3Q 2022 up 30325.23 % up 7298.86 % - -
Cnbx Pharmaceuticals Inc 4Q 2022 - - - -
Cns Pharmaceuticals Inc 3Q 2024 - - - -
Centessa Pharmaceuticals Plc 2Q 2024 - - - -
Connect Biopharma Holdings Limited 4Q 2023 - - - -
Context Therapeutics Inc 3Q 2022 - - - -
Cocrystal Pharma Inc 2Q 2022 - - - -
Cogent Biosciences Inc 3Q 2023 - - - -
Collegium Pharmaceutical inc 3Q 2022 up 13.84 % down -34.78 % down -94.32 % -
Corcept Therapeutics Inc 3Q 2024 up 47.69 % up 11.45 % up 49.78 % up 32.94 %
Coya Therapeutics Inc 2Q 2024 - up 2600.51 % - -
China Pharma Holdings Inc 2Q 2022 down-33.22 % up 0.57 % - -
Cumberland Pharmaceuticals Inc 3Q 2022 up 41.38 % up 10.82 % - -
Cannapharmarx Inc 3Q 2023 - - - -
Catalyst Pharmaceuticals Inc 3Q 2022 up 59.21 % up 7.78 % up 120.23 % up 5.22 %
Corbus Pharmaceuticals Holdings Inc 2Q 2022 - - - -
Cormedix Inc 3Q 2024 - up 1321.14 % - -
Crinetics Pharmaceuticals Inc 3Q 2022 - up 4.33 % - -
Cervomed Inc 1Q 2024 - down -58.22 % - -
Corvus Pharmaceuticals Inc 3Q 2023 - - - -
Cti Biopharma Corp 1Q 2022 - - - -
Innovation Pharmaceuticals Inc 3Q 2021 - - - -
Catalent Inc 3Q 2022 down-13.99 % down -29.55 % - -
Cytomx Therapeutics Inc 3Q 2022 down-3.82 % down -6.88 % - -
Contineum Therapeutics Inc 3Q 2024 - - - -
Citius Pharmaceuticals Inc 2Q 2022 - - - -
Cue Biopharma Inc 3Q 2023 up 2988.24 % up 51.95 % - -
Curevac N v 4Q 2023 up 10 % up 10 % - -
Cadrenal Therapeutics Inc 3Q 2023 - - - -
Cv Sciences Inc 2Q 2024 up 3.82 % up 0.18 % - -
Cohbar Inc 2Q 2022 - - - -
Cybin Inc 1Q 2024 - - - -
Cyclacel Pharmaceuticals Inc 2Q 2022 - - - -
Cyclerion Therapeutics Inc 2Q 2022 down-89.8 % down -56.96 % - -
Cytodyn inc 4Q 2022 - - - -
Cryoport inc 3Q 2024 up 0.9 % down -1.62 % - -
Cyteir Therapeutics Inc 2Q 2022 - - - -
Cytokinetics Incorporated 3Q 2024 up 22.49 % up 85.94 % - -
Altamira Therapeutics Ltd 4Q 2023 - - - -
Dare Bioscience Inc 3Q 2023 - - - -
Day One Biopharmaceuticals Inc 3Q 2022 - - - -
Decibel Therapeutics Inc 2Q 2023 - - - -
Deciphera Pharmaceuticals Inc 1Q 2024 up 34.55 % down -6.82 % - -
Denali Capital Acquisition Corp 3Q 2024 - - - -
Journey Medical Corp 3Q 2022 down-17.82 % down -11.89 % - -
Dice Therapeutics Inc 2Q 2023 - - - -
Diamedica Therapeutics Inc 3Q 2022 - - - -
Dmk Pharmaceuticals Corporation 3Q 2021 down-82.33 % down -81.05 % - -
Dianthus Therapeutics Inc 2Q 2024 - up 113.16 % - -
Dermata Therapeutics Inc 3Q 2024 - - - -
Durect Corp 3Q 2024 up 10.49 % down -11.24 % - -
Bright Minds Biosciences Inc 3Q 2023 - - - -
Design Therapeutics Inc 3Q 2022 - - - -
Dynavax Technologies Corporation 3Q 2022 up 56.37 % down -34.34 % - down -50.44 %
Dogwood Therapeutics inc 3Q 2024 - - - -
Dyne Therapeutics Inc 3Q 2024 - - - -
Emergent Biosolutions Inc 3Q 2024 up 8.61 % up 15.35 % - -
Edesa Biotech Inc 3Q 2022 - - - -
Effector Therapeutics Inc 1Q 2024 - - - -
Eagle Pharmaceuticals inc 2Q 2021 up 14.75 % up 16.67 % - -
Elevai Labs Inc 3Q 2024 - down -99.9 % - -
Elanco Animal Health Inc 3Q 2024 down-3.56 % down -13.01 % - -
Eledon Pharmaceuticals Inc 2Q 2024 - - - -
Elite Pharmaceuticals Inc 3Q 2022 down-8.58 % up 11.81 % down -15.68 % up 395.33 %
Elicio Therapeutics Inc 2Q 2022 up 20.93 % down -60.38 % - -
Enliven Therapeutics Inc 3Q 2024 - - - -
Emmaus Life Sciences Inc 3Q 2024 up 9.17 % up 1.88 % up 2626.87 % -
Endo International Plc 4Q 2023 down-10.45 % up 10.2 % - -
Enlivex Therapeutics Ltd 4Q 2023 - - - -
Ensysce Biosciences Inc 2Q 2022 down-53.33 % down -65.6 % - -
Enanta Pharmaceuticals Inc 3Q 2024 down-22.84 % down -18.72 % - -
Entero Therapeutics Inc 2Q 2024 - - - -
Enveric Biosciences Inc 3Q 2022 - - - -
Evolus Inc 3Q 2022 up 27.07 % down -8.78 % - -
Essa Pharma inc 3Q 2022 - - - -
Equillium Inc 3Q 2024 up 37.1 % down -12.21 % - -
Eqrx Inc 3Q 2021 - - - -
Erasca Inc 3Q 2022 - - - -
Eterna Therapeutics Inc 3Q 2024 up 854.9 % up 936.17 % - -
Esperion Therapeutics Inc 3Q 2024 up 52 % down -30.07 % - -
89bio Inc 2Q 2024 - - - -
Eton Pharmaceuticals Inc 3Q 2022 up 315.35 % down -56.25 % - -
Earth Science Tech Inc 3Q 2022 - - - -
Evofem Biosciences Inc 3Q 2024 down-12.05 % up 8.08 % - -
Evelo Biosciences Inc 3Q 2023 - - - -
Evotec Se 4Q 2023 up 3.99 % up 3.99 % - -
Evoke Pharma Inc 3Q 2024 up 69.83 % up 4.03 % - -
Edgewise Therapeutics inc 2Q 2023 - - - -
Eyenovia inc 3Q 2023 - - - -
Fortress Biotech Inc 2Q 2022 up 5.85 % down -21.06 % - -
Fibrobiologics Inc 3Q 2024 - - - -
Forte Biosciences Inc 3Q 2022 - - - -
Fibrogen Inc 3Q 2024 up 15.45 % down -8.51 % - -
Foghorn Therapeutics Inc 3Q 2022 up 16080.49 % up 47.75 % - -
Flora Growth Corp 4Q 2023 - down -91.48 % - -
Amicus Therapeutics inc 3Q 2024 up 37.72 % up 11.73 % - -
Fulcrum Therapeutics Inc 3Q 2022 down-76.03 % down -37.14 % - -
Galectin Therapeutics Inc 1Q 2023 - - - -
Gain Therapeutics Inc 2Q 2024 - - - -
Generation Bio Co 3Q 2024 up 252 % up 84.65 % - -
The Greater Cannabis Company Inc 2Q 2022 - - - -
Geron Corp 3Q 2022 up 172.48 % up 306.85 % - -
Gh Research Plc 4Q 2023 - - - -
Guardion Health Sciences Inc 2Q 2022 up 96.09 % up 14.46 % - -
Galmed Pharmaceuticals Ltd 4Q 2023 - - down -61.31 % down -61.31 %
Galapagos Nv 4Q 2023 down-52.56 % down -52.56 % - -
Gelesis Holdings Inc 2Q 2021 - - - -
Greenwich Lifesciences Inc 1Q 2022 - - - -
Galecto Inc 2Q 2022 - - - -
Glycomimetics Inc 2Q 2024 - - - -
Genelux Corporation 2Q 2024 - - - -
Genprex Inc 3Q 2022 - - - -
Gossamer Bio Inc 3Q 2022 - - - -
Geovax Labs Inc 2Q 2022 - - - -
Structure Therapeutics Inc 3Q 2023 - - - -
Grifols Sa 4Q 2023 - - down -33.37 % down -33.37 %
Gri Bio Inc 3Q 2022 - - - -
Galera Therapeutics Inc 3Q 2022 - - - -
Globestar Therapeutics Corporation 2Q 2022 - - - -
Gt Biopharma Inc 2Q 2024 - - - -
G1 Therapeutics Inc 2Q 2022 up 60.1 % up 53.19 % - -
Gyre Therapeutics Inc 3Q 2024 - up 1.04 % - down -37.06 %
Hutchmed china Limited 4Q 2023 up 96.52 % up 96.52 % - -
Hcw Biologics Inc 3Q 2022 - up 298.46 % - -
Hepion Pharmaceuticals Inc 3Q 2022 - - - -
Humanigen Inc 1Q 2023 down-78.67 % flat 0 % - -
Hookipa Pharma inc 3Q 2024 down-31.51 % up 264.57 % - -
Hoth Therapeutics Inc 2Q 2022 - - - -
Werewolf Therapeutics Inc 3Q 2022 - up 19.82 % - -
Inhibitor Therapeutics Inc 1Q 2024 - - - -
Harmony Biosciences Holdings inc 2Q 2024 up 28.65 % up 12.03 % down -66.21 % down -69.76 %
Harrow Inc 3Q 2022 up 21.98 % down -2.14 % - -
Heron Therapeutics Inc 3Q 2023 up 17.58 % down -1.69 % - -
Hst Global Inc 2Q 2022 - - - -
Histogen Inc 3Q 2021 up 19.39 % up 11720 % - -
Fsd Pharma Inc 4Q 2023 - - - -
Tuhura Biosciences Inc 3Q 2024 - - - -
Horizon Therapeutics Public Limited Company 2Q 2023 up 7.71 % up 13.45 % up 108.4 % up 132.37 %
Ibio inc 2Q 2024 - - - -
Intercept Pharmaceuticals inc 3Q 2022 down-16.42 % up 8.13 % - -
Ideaya Biosciences Inc 3Q 2023 down-72.94 % up 126.81 % - -
Inflarx N v 4Q 2023 - - - -
India Globalization Capital Inc 3Q 2024 down-25.77 % up 51.47 % - -
Igm Biosciences Inc 3Q 2022 - - - -
Intelgenx Technologies Corp 3Q 2021 up 1311.9 % up 107.34 % - -
I mab 4Q 2023 - - - -
Immunogen inc 2Q 2022 down-16.44 % down -62.81 % - -
Immutep Limited 2Q 2024 up 50.74 % up 50.74 % - -
Immix Biopharma Inc 3Q 2022 - - - -
Immunome Inc 1Q 2024 - down -71.14 % - -
Imunon Inc 3Q 2022 flat 0 % flat 0 % - -
Impel Pharmaceuticals Inc 3Q 2023 up 55.52 % down -24.69 % - -
Immuron Limited 2Q 2023 - - - -
Immuneering Corporation 3Q 2024 - - - -
Immunic Inc 3Q 2024 - - - -
Integrated Biopharma Inc 3Q 2022 down-3.33 % down -7.09 % - -
Intercure Ltd 4Q 2023 down-8.52 % down -8.52 % - -
Indaptus Therapeutics Inc 2Q 2022 - - - -
Indivior Plc 4Q 2023 - - - -
Infinity Pharmaceuticals Inc 2Q 2023 down-15.01 % down -20.25 % - -
Inmed Pharmaceuticals Inc 1Q 2022 - up 16.78 % - -
Insmed Inc 3Q 2022 up 44.86 % up 3.85 % - -
Innoviva Inc 1Q 2022 up 5.31 % down -16.36 % down -65.49 % down -17.07 %
Inozyme Pharma Inc 3Q 2022 - - - -
Io Biotech Inc 3Q 2022 - - - -
Ionis Pharmaceuticals Inc 3Q 2021 down-16.86 % up 5.84 % - -
Immunoprecise Antibodies Ltd 1Q 2024 up 18.65 % up 18.65 % - -
Disc Medicine Inc 3Q 2022 - - - -
Ironwood Pharmaceuticals inc 3Q 2023 up 4.7 % up 5.92 % down -72.28 % -
International Stem Cell Corporation 3Q 2022 down-7.55 % down -15.98 % - -
Iveric Bio Inc 1Q 2022 - - - -
Intra cellular Therapies Inc 3Q 2022 up 223.63 % up 29.31 % - -
Iterum Therapeutics Plc 2Q 2024 - - - -
Inventiva S a 4Q 2023 up 233.69 % up 233.69 % - -
Incannex Healthcare Inc 2Q 2024 - - - -
Jaguar Health Inc 3Q 2022 up 400 % up 7.84 % - -
Janux Therapeutics Inc 3Q 2022 up 56.43 % down -23.34 % - -
Jazz Pharmaceuticals Plc 3Q 2024 up 8.52 % up 3.04 % up 46.48 % up 27.58 %
Johnson and Johnson 3Q 2024 up 5.25 % up 0.11 % down -89.65 % down -42.51 %
Kala Bio inc 3Q 2022 down-86.31 % down -80 % - -
Kalvista Pharmaceuticals Inc 3Q 2022 - - - -
Kineta Inc 3Q 2024 - - - -
Kairos Pharma Ltd 3Q 2024 - - - -
Chinook Therapeutics Inc 2Q 2021 down-99.39 % down -90.31 % - -
Kamada Ltd 4Q 2023 up 10.19 % up 10.19 % - -
Kiniksa Pharmaceuticals International Plc 3Q 2024 up 67.37 % up 3.3 % - -
Kinnate Biopharma Inc 3Q 2021 - - - -
Kiora Pharmaceuticals Inc 3Q 2024 - - - -
Karyopharm Therapeutics Inc 3Q 2022 down-4.1 % down -8.91 % - -
Kronos Bio Inc 3Q 2024 up 158.45 % down -11.83 % - -
Keros Therapeutics Inc 3Q 2022 - - - -
Korro Bio Inc 3Q 2024 - - - -
Karuna Therapeutics Inc 3Q 2023 - - - -
Pasithea Therapeutics Corp 1Q 2022 - down -94.58 % - -
Kura Oncology Inc 3Q 2022 - - - -
Kazia Therapeutics Limited 2Q 2024 up 248000 % up 248000 % - -
Kezar Life Sciences Inc 3Q 2024 - - - -
Landos Biopharma Inc 4Q 2023 - - - -
Longboard Pharmaceuticals Inc 3Q 2022 - - - -
Lannett Company Inc 1Q 2023 up 1.41 % up 9.29 % - -
Legend Biotech Corporation 4Q 2023 up 217.56 % up 217.56 % - -
Lexaria Bioscience Corp 4Q 2024 up 21.58 % up 118.96 % - -
Lifecore Biomedical Inc 4Q 2024 up 7.1 % up 31.56 % - -
Lifevantage Corp 3Q 2022 down-2.72 % up 1.63 % down -81.6 % -
Ligand Pharmaceuticals Incorporated 2Q 2022 down-32.19 % up 25.66 % - -
Longeveron Inc 2Q 2022 down-4.7 % up 25.95 % - -
Lianbio 3Q 2023 - - - -
Lftd Partners Inc 3Q 2023 up 16.63 % up 4.66 % up 45.85 % down -62.78 %
Lipella Pharmaceuticals Inc 2Q 2024 up 27.89 % down -6.48 % - -
Lixte Biotechnology Holdings Inc 3Q 2024 - - - -
Eli Lilly And Company 3Q 2024 up 20.43 % up 1.21 % - down -67.3 %
Lipocine Inc 2Q 2022 up 389.53 % - - -
Leap Therapeutics Inc 3Q 2022 - - - -
Liquidia Corporation 3Q 2022 down-0.43 % down -19.22 % - -
Larimar Therapeutics Inc 3Q 2023 - - - -
Lakeshore Biopharma Co Ltd 1Q 2024 down-19.18 % down -19.18 % - -
Lucy Scientific Discovery Inc 4Q 2023 - - - -
Lisata Therapeutics Inc 3Q 2024 - - - -
Lantern Pharma Inc 2Q 2022 - - - -
Lumos Pharma Inc 3Q 2024 up 10271.43 % up 48.77 % - -
Lexicon Pharmaceuticals Inc 3Q 2024 up 980.25 % up 6.25 % - -
Lyell Immunopharma Inc 3Q 2024 up 36 % up 161.54 % - -
Merrimack Pharmaceuticals Inc 1Q 2022 - - - -
Maia Biotechnology Inc 3Q 2024 - - - -
Mustang Bio inc 3Q 2023 - - - -
Moleculin Biotech Inc 3Q 2022 - - - -
Mbx Biosciences Inc 3Q 2024 - - - -
Seres Therapeutics Inc 3Q 2024 - - - -
Madrigal Pharmaceuticals Inc 3Q 2022 - - - -
23andme Holding Co 3Q 2022 up 37.05 % up 17.28 % - -
Mei Pharma Inc 3Q 2024 - - - -
Macrogenics Inc 3Q 2024 up 964.81 % up 925.36 % up 220.78 % -
Mira Pharmaceuticals Inc 3Q 2024 - - - -
Mirum Pharmaceuticals Inc 3Q 2024 up 89.37 % up 16.05 % - -
Milestone Pharmaceuticals Inc 3Q 2023 - - - -
Moonlake Immunotherapeutics 3Q 2023 - - - -
Mineralys Therapeutics Inc 3Q 2024 - - - -
Mallinckrodt Plc 2Q 2023 up 24.03 % up 12.06 % - -
Mannkind Corporation 3Q 2024 up 36.73 % down -3.19 % up 571.12 % -
Medicinova Inc 3Q 2024 - - - -
Monopar Therapeutics Inc 2Q 2024 - - - -
Morphosys Ag 4Q 2023 down-14.37 % down -14.37 % - -
Morphic Holding inc 2Q 2022 up 1465.38 % up 2428.8 % - -
Medicure Inc 4Q 2023 down-5.94 % down -5.94 % - -
Mereo Biopharma Group Plc 3Q 2024 - - - -
Merck and Co Inc 3Q 2022 up 13.72 % up 2.51 % down -28.83 % down -17.62 %
Marker Therapeutics inc 1Q 2024 down-73.72 % - - -
Marinus Pharmaceuticals Inc 2Q 2022 down-6.04 % down -87.38 % - -
Mersana Therapeutics inc 3Q 2023 up 38.13 % down -27.75 % - -
Mirati Therapeutics Inc 3Q 2023 up 201.97 % up 19.8 % - -
Merus N v 2Q 2024 down-30.01 % down -7.06 % - -
Maravai Lifesciences Holdings Inc 2Q 2024 down-7.12 % up 14.37 % - -
Molecular Templates Inc 2Q 2024 down-78.09 % down -94.84 % - -
Matinas Biopharma Holdings Inc 2Q 2022 up 3087.53 % - - -
Mural Oncology Plc 3Q 2024 - - - -
Mainz Biomed N v 4Q 2023 up 69 % up 69 % - -
Innovation1 Biotech Inc 3Q 2021 - - - -
Newamsterdam Pharma Company N v 3Q 2024 - up 1177.36 % - -
Nature s Sunshine Products inc 3Q 2024 up 3.19 % up 3.52 % up 47.87 % up 212.23 %
Nascent Biotech Inc 2Q 2022 down-50 % down -100 % - -
Nabriva Therapeutics Plc 2Q 2021 up 1592.61 % up 225.94 % - -
Neubase Therapeutics inc 3Q 2023 - - - -
Nanobiotix S a 4Q 2023 up 658.1 % up 658.1 % - -
Novabay Pharmaceuticals Inc 3Q 2022 up 83.42 % up 32.35 % - -
Nucana Plc 4Q 2023 - - - -
Neptune Wellness Solutions Inc 4Q 2023 down-37.75 % down -13.05 % - -
Minerva Neurosciences Inc 3Q 2022 - - - -
Neximmune Inc 2Q 2024 - - - -
Ngm Biopharmaceuticals Inc 4Q 2023 down-99.09 % down -71.65 % - -
Neurogene Inc 3Q 2024 - - - -
Nektar Therapeutics 3Q 2024 down-0.08 % up 2.7 % - -
Nkarta Inc 3Q 2024 - - - -
Nls Pharmaceutics Ltd 4Q 2023 - - - -
9 Meters Biopharma Inc 1Q 2023 - - - -
Nanoviricides inc 3Q 2022 - - - -
Novan Inc 1Q 2021 down-32.48 % down -23.39 % - -
Neurobo Pharmaceuticals Inc 3Q 2022 - - - -
Nurix Therapeutics Inc 3Q 2024 down-31.84 % up 4.1 % - -
Neurosense Therapeutics Ltd 4Q 2023 - - - -
Nrx Pharmaceuticals Inc 2Q 2024 - - - -
Rebus Holdings Inc 2Q 2021 - - - -
Notable Labs Ltd 2Q 2024 - up 100 % - -
Nuvation Bio Inc 3Q 2022 - - - -
Nuvalent Inc 3Q 2022 - - - -
Nuvectis Pharma inc 3Q 2024 - - - -
Novartis Ag 4Q 2023 down-9.97 % down -9.97 % up 113.57 % up 113.57 %
Northwest Biotherapeutics inc 1Q 2023 up 118.36 % up 47.4 % - -
Nexien Biopharma Inc 3Q 2022 - - - -
Nextcure Inc 3Q 2023 - - - -
Theralink Technologies Inc 4Q 2023 down-72.5 % down -58.53 % - -
Ocean Biomedical Inc 4Q 2023 - - - -
Oculis Holding Ag 4Q 2023 down-3.18 % down -3.18 % - -
Ocular Therapeutix Inc 3Q 2024 up 2.28 % down -6.18 % - -
Ocuphire Pharma Inc 2Q 2024 down-36.42 % down -35.01 % - -
Oragenics Inc 2Q 2023 down-56.69 % down -22.68 % - -
Organigram Holdings Inc 3Q 2023 - - - -
Organon and Co 3Q 2024 up 4.15 % down -1.56 % up 518.97 % up 84.1 %
Onkure Therapeutics Inc 3Q 2022 - - - -
Olema Pharmaceuticals Inc 3Q 2022 - - - -
Omeros Corporation 3Q 2024 - - - -
Oncorus Inc 1Q 2021 - - - -
Oncternal Therapeutics Inc 3Q 2022 down-82.05 % up 100 % - -
Oncolytics Biotech Inc 4Q 2023 - - - -
Opko Health Inc 2Q 2023 down-14.35 % up 11.72 % - -
Optinose Inc 3Q 2022 down-8.01 % down -2.45 % - -
Organogenesis Holdings Inc 3Q 2024 up 6.12 % down -11.56 % up 289.36 % -
Orgenesis Inc 3Q 2022 down-7.93 % up 10.93 % down -86.13 % down -74.36 %
Oric Pharmaceuticals Inc 2Q 2023 - - - -
Oramed Pharmaceuticals Inc 1Q 2022 down-1.19 % down -1.19 % up 92.24 % up 32.23 %
Os Therapies Incoporated 3Q 2024 - - - -
Oncotelic Therapeutics Inc 3Q 2022 - - - -
Ovid Therapeutics Inc 3Q 2024 up 58.76 % up 2.37 % - -
One World Products Inc 3Q 2024 down-74.31 % up 20.97 % - -
Phibro Animal Health Corporation 3Q 2024 up 12.47 % down -5.35 % - up 827.53 %
Prestige Consumer Healthcare Inc 3Q 2022 up 4.72 % up 4.41 % up 12.06 % down -6.78 %
Panbela Therapeutics Inc 3Q 2024 - - - -
Psyence Biomedical ltd 1Q 2024 down-20 % down -20 % - -
Puma Biotechnology Inc 2Q 2023 down-8.32 % up 3.4 % down -77.31 % up 51.75 %
Rapid Therapeutic Science Laboratories Inc 2Q 2021 down-95.36 % - - -
Pacira Biosciences inc 2Q 2022 up 24.94 % up 7.23 % up 4.17 % up 191.1 %
Processa Pharmaceuticals Inc 3Q 2024 - - - -
Procyon Corporation 2Q 2024 up 17.51 % up 17.87 % up 1159.27 % -
Pds Biotechnology Corp 2Q 2024 - - - -
Pepgen Inc 2Q 2023 - - - -
Pfizer Inc 3Q 2022 down-6.04 % down -18.4 % up 5.69 % down -13 %
Precigen Inc 3Q 2022 down-22.44 % up 474.44 % - -
Pharming Group N v 4Q 2023 up 19.2 % up 19.2 % - -
Phathom Pharmaceuticals Inc 3Q 2022 - - - -
Phio Pharmaceuticals Corp 3Q 2024 - - - -
Pieris Pharmaceuticals Inc 3Q 2023 up 263.5 % down -2.67 % - -
Protokinetix Incorporated 3Q 2024 - - - -
Pliant Therapeutics Inc 2Q 2022 up 178.87 % up 299.44 % - -
Promis Neurosciences inc 3Q 2022 - - - -
Pmv Pharmaceuticals Inc 3Q 2024 - - - -
Point Biopharma Global Inc 2Q 2021 - - - -
Propanc Biopharma Inc 1Q 2024 - - - -
Praxis Precision Medicines Inc 3Q 2024 down-35.47 % down -15.41 % - -
Pardes Biosciences Inc 2Q 2023 - - - -
Perrigo Company Plc 3Q 2022 up 5.49 % down -1.89 % - -
Prelude Therapeutics Inc 3Q 2022 - - - -
Prophase Labs Inc 3Q 2024 down-65.95 % up 86.02 % - -
Proqr Therapeutics N v 4Q 2023 - - - -
Prothena Corporation Public Limited Company 3Q 2024 down-98.86 % down -99.27 % - -
Puretech Health Plc 4Q 2023 down-78.68 % down -78.68 % - -
Portage Biotech Inc 1Q 2024 - - - -
Paratek Pharmaceuticals Inc 1Q 2021 up 107.41 % up 2.55 % - -
Ptc Therapeutics inc 1Q 2022 up 26.11 % down -9.98 % - -
Protagonist Therapeutics inc 3Q 2024 - up 12.19 % - -
Protagenic Therapeutics Inc new 3Q 2024 - - - -
Palatin Technologies Inc 3Q 2022 up 445.3 % up 3.18 % - -
Petros Pharmaceuticals inc 3Q 2024 - down -1.34 % - -
Pulmatrix Inc 3Q 2022 up 75.12 % up 40.65 % - -
Provectus Biopharmaceuticals Inc 3Q 2022 - down -2.12 % - -
Powerup Acquisition Corp 3Q 2022 - - - up 792.53 %
Paxmedica Inc 2Q 2024 - - - -
Pyxis Oncology Inc 2Q 2024 - - - -
Q Biomed inc 1Q 2023 - - - -
Qualigen Therapeutics Inc 3Q 2024 - - - -
Qilian International Holding Group Limited 3Q 2023 down-29.46 % down -29.46 % - -
Quoin Pharmaceuticals Ltd 3Q 2024 - - - -
Q32 Bio Inc 3Q 2024 - - - -
Uniqure N v 3Q 2024 down-5.57 % down -79.44 % - -
Rain Oncology Inc 3Q 2023 - - - -
Rani Therapeutics Holdings Inc 3Q 2024 - - - -
Rapport Therapeutics Inc 3Q 2024 - - - -
Rapt Therapeutics Inc 3Q 2022 - - - -
Ultragenyx Pharmaceutical Inc 2Q 2024 up 35.75 % up 35.09 % - -
Actavia Life Sciences Inc 1Q 2024 - - - -
Rocket Pharmaceuticals Inc 3Q 2024 - - - -
Arcus Biosciences Inc 3Q 2024 up 50 % up 23.08 % - -
Redhill Biopharma Ltd 4Q 2023 down-89.43 % down -89.43 % down -66.63 % down -66.63 %
Dr Reddy s Laboratories Limited 1Q 2024 up 11.97 % up 11.97 % up 21.9 % up 21.9 %
Regeneron Pharmaceuticals Inc 3Q 2022 down-14.96 % up 2.76 % down -19.39 % up 54.41 %
Renovaro Inc 3Q 2022 - - - -
Reata Pharmaceuticals Inc 2Q 2023 up 2885.04 % up 11564.62 % - -
Revelation Biosciences Inc 3Q 2024 - - - -
Rafael Holdings Inc 1Q 2022 down-11.62 % down -21.17 % - -
Regen Biopharma Inc 2Q 2022 up 14.1 % up 1.12 % up 4298.09 % -
Regulus Therapeutics Inc 2Q 2022 - - - -
Regenerx Biopharmaceuticals inc 1Q 2021 up 0.01 % up 0.01 % - -
Rigel Pharmaceuticals Inc 2Q 2022 up 13.53 % up 78.18 % - -
Relmada Therapeutics Inc 1Q 2022 - - - -
Rallybio Corporation 3Q 2023 - - - -
Rockwell Medical inc 2Q 2022 up 17.23 % up 16.64 % - -
Avidity Biosciences Inc 2Q 2022 down-16.46 % up 21.34 % - -
Cartesian Therapeutics Inc 3Q 2024 down-94.09 % down -98.84 % - -
Transcode Therapeutics Inc 3Q 2022 - - - -
Renovorx Inc 3Q 2022 - - - -
Roivant Sciences Ltd 2Q 2024 up 154.96 % up 90.57 % - -
Royalty Pharma Plc 3Q 2022 down-2.1 % up 7 % down -0.62 % down -55.16 %
Repare Therapeutics Inc 3Q 2022 - up 16475.11 % - -
Reshape Lifesciences Inc 3Q 2024 up 6.36 % up 16.64 % - -
Respirerx Pharmaceuticals Inc 2Q 2023 - - - -
Rvl Pharmaceuticals Plc 2Q 2023 down-13.45 % down -17.21 % - -
Revance Therapeutics Inc 3Q 2022 up 46.95 % up 2.28 % - -
Reviva Pharmaceuticals Holdings Inc 3Q 2022 - - - -
Prometheus Biosciences Inc 4Q 2021 - up 3.08 % - -
Rhythm Pharmaceuticals inc 3Q 2024 up 72.99 % up 14.35 % - -
Rayzebio Inc 3Q 2023 - - - -
Rezolute Inc 2Q 2024 - - - -
Sage Therapeutics Inc 2Q 2022 down-8.64 % down -5.12 % - -
Cassava Sciences Inc 3Q 2022 - - - -
Sunshine Biopharma Inc 3Q 2024 up 41.59 % down -9.33 % - -
Scienture Holdings Inc 3Q 2024 down-96.85 % up 246.87 % - -
Scpharmaceuticals Inc 2Q 2022 - - - -
Scopus Biopharma Inc 1Q 2023 - - - -
Scorpius Holdings inc 3Q 2024 up 27.55 % up 21.37 % - -
Societal Cdmo Inc 4Q 2021 up 124.99 % up 22.3 % - -
Scynexis Inc 3Q 2024 down-62.52 % down -10.33 % - -
Schrodinger Inc 3Q 2024 down-16.6 % down -25.05 % - -
Seelos Therapeutics inc 2Q 2024 down-10.26 % down -36.16 % - -
Septerna Inc 3Q 2024 - - - -
Serina Therapeutics Inc 3Q 2024 up 55.56 % down -72.55 % - down -73.29 %
Sangui Biotech International Inc 1Q 2023 up 4.14 % up 75.94 % - -
Sagimet Biosciences inc 1Q 2024 - - - -
Sigilon Therapeutics Inc 2Q 2021 - down -8.59 % - -
Shuttle Pharmaceuticals Holdings Inc 3Q 2022 - - - -
Siga Technologies Inc 3Q 2024 up 8.39 % down -54.11 % - down -26.67 %
Silo Pharma Inc 3Q 2024 flat 0 % flat 0 % - -
Skinvisible Inc 3Q 2024 flat 0 % flat 0 % - -
Skye Bioscience Inc 2Q 2022 - - - -
Sol gel Technologies Ltd 4Q 2023 down-59.98 % down -59.98 % - -
Silence Therapeutics Plc 4Q 2023 up 43.17 % up 43.17 % - -
Acelyrin Inc 2Q 2024 - - - -
Salarius Pharmaceuticals inc 1Q 2024 - - - -
Sellas Life Sciences Group Inc 3Q 2024 - - - -
Summit Therapeutics Inc 3Q 2022 up 285.96 % down -6.38 % - -
Syndax Pharmaceuticals Inc 3Q 2022 - - - -
Soligenix inc 3Q 2024 - - - -
Synaptogenix Inc 3Q 2024 - - up 327.67 % up 301.03 %
Sensei Biotherapeutics Inc 3Q 2024 - - - -
Sanofi 4Q 2023 up 2.32 % up 2.32 % down -35.93 % down -35.93 %
Sonnet Biotherapeutics Holdings Inc 2Q 2022 - down -34.88 % - -
Spectrum Pharmaceuticals Inc 1Q 2021 - - - -
Spruce Biosciences Inc 3Q 2024 down-80.41 % down -62.61 % - -
Spero Therapeutics Inc 3Q 2024 down-47.12 % up 32.09 % - -
Ars Pharmaceuticals Inc 3Q 2024 - up 313.6 % - -
Sarepta Therapeutics Inc 3Q 2022 up 21.57 % down -1.38 % - -
Stoke Therapeutics Inc 3Q 2022 - down -10.09 % - -
Satsuma Pharmaceuticals Inc 1Q 2021 - - - -
Shattuck Labs Inc 2Q 2022 - - - -
Supernus Pharmaceuticals inc 3Q 2024 up 29.6 % up 4.37 % - up 93.3 %
Savara Inc 3Q 2023 - - - -
60 Degrees Pharmaceuticals Inc 2Q 2024 - up 109.92 % - -
Synlogic Inc 2Q 2022 down-38.21 % down -37.7 % - -
Spyre Therapeutics Inc 3Q 2022 down-87.56 % down -72.16 % - -
Syros Pharmaceuticals Inc 1Q 2024 - - - -
Takeda Pharmaceutical Company Limited 1Q 2024 up 4.53 % up 4.53 % down -55.09 % down -55.09 %
Taro Pharmaceutical Industries Ltd 1Q 2023 up 2.07 % up 2.07 % down -56.33 % down -56.33 %
Theravance Biopharma inc 2Q 2022 down-14.43 % down -16.26 % - -
Alaunos Therapeutics Inc 3Q 2024 - - - -
Telomir Pharmaceuticals Inc 3Q 2024 - - - -
Citius Oncology Inc 2Q 2024 - - down -59.04 % down -48.46 %
Tenax Therapeutics Inc 3Q 2024 - - up 100.84 % up 10.76 %
Terns Pharmaceuticals Inc 2Q 2024 - - - -
Teva Pharmaceutical Industries Limited 3Q 2022 down-7.51 % down -5.04 % down -80.79 % -
Tff Pharmaceuticals Inc 4Q 2022 up 600.73 % up 1151.13 % - -
Tg Therapeutics Inc 2Q 2022 down-61.55 % down -70.54 % - -
Tharimmune Inc 2Q 2024 - - - -
Third Harmonic Bio Inc 3Q 2024 - - up 87.92 % up 28.88 %
Thorne Healthtech Inc 2Q 2022 - up 2.56 % - -
Theseus Pharmaceuticals Inc 3Q 2023 - - - -
Theratechnologies Inc 4Q 2023 - - - -
Talphera Inc 3Q 2022 down-72.77 % down -11.05 % - -
Tiziana Life Sciences Ltd 4Q 2023 - - - -
Timber Pharmaceuticals Inc 2Q 2021 - up 854.53 % - -
Tango Therapeutics Inc 3Q 2024 up 8.15 % down -41.6 % - -
Tonix Pharmaceuticals Holding Corp 3Q 2024 down-29.26 % up 27.81 % - -
Theriva Biologics inc 4Q 2021 - - - -
Tempest Therapeutics Inc 3Q 2022 - - - -
Traws Pharma inc 3Q 2024 up 1.79 % up 1.79 % - -
Entrada Therapeutics Inc 2Q 2023 - down -28.07 % - -
Trevi Therapeutics Inc 3Q 2023 - - - -
Trevena inc 3Q 2022 - - - -
2seventy Bio Inc 3Q 2024 up 12.46 % up 50.93 % - -
Travere Therapeutics Inc 3Q 2022 down-21.58 % down -1.24 % - -
Therapeuticsmd Inc 2Q 2024 down-46.45 % flat 0 % - -
Tyra Biosciences Inc 3Q 2022 - - - -
Unity Biotechnology Inc 2Q 2022 - - - -
Unicycive Therapeutics Inc 2Q 2022 - - - -
Upstream Bio Inc 3Q 2024 - - - -
Universe Pharmaceuticals Inc 3Q 2023 down-19.52 % down -19.52 % - -
Urogen Pharma Ltd 3Q 2022 up 41.81 % down -3.05 % - -
United Therapeutics Corporation 3Q 2022 up 16.03 % up 10.52 % up 47.08 % up 106.29 %
Avricore Health Inc 4Q 2023 up 41.87 % up 41.87 % - -
Vaxxinity Inc 4Q 2021 - up 31900 % - -
Vbi Vaccines Inc 1Q 2024 up 150.31 % up 42.32 % - -
Vaccinex Inc 4Q 2022 - up 350 % - -
Vera Therapeutics Inc 2Q 2024 - - - -
Veru Inc 3Q 2022 down-83.46 % down -73.04 % - -
Verve Therapeutics Inc 3Q 2024 up 120.24 % up 2.59 % - -
Viveon Health Acquisition Corp 4Q 2022 - - - -
Vincerx Pharma Inc 3Q 2024 - - - -
Viracta Therapeutics Inc 3Q 2022 - - - -
Viking Therapeutics Inc 2Q 2023 - - - -
Vanda Pharmaceuticals Inc 3Q 2024 up 22.76 % down -5.59 % - -
Verrica Pharmaceuticals Inc 3Q 2022 - up 3787.38 % - -
Verona Pharma Plc 3Q 2024 - - - -
Virpax Pharmaceuticals Inc 2Q 2023 - - - -
Vertex Pharmaceuticals Inc 3Q 2022 up 17.65 % up 6.29 % up 9.22 % up 14.81 %
Verastem Inc 3Q 2023 - - - -
Vistagen Therapeutics Inc 3Q 2022 - - - -
Viatris Inc 3Q 2022 down-10.1 % down -0.94 % up 13.74 % up 12.87 %
Vtv Therapeutics Inc 3Q 2022 - - - -
Ventyx Biosciences Inc 3Q 2022 - - - -
Vyne Therapeutics Inc 3Q 2022 down-95.91 % up 32.54 % - -
Wave Life Sciences Ltd 3Q 2024 - - - -
Xenetic Biosciences Inc 2Q 2022 up 44.89 % up 7.13 % - -
Xbiotech Inc 3Q 2024 - - - -
Exicure Inc 3Q 2024 - - - -
Xenon Pharmaceuticals Inc 3Q 2024 - - - -
Xeris Biopharma Holdings Inc 3Q 2022 up 168.76 % up 17.46 % - flat 0 %
Xilio Therapeutics inc 3Q 2022 - - - -
Xencor Inc 3Q 2024 down-81.9 % down -36.85 % - -
Xoma Royalty Corporation 3Q 2022 down-49.94 % down -54.12 % - -
Xortx Therapeutics inc 4Q 2023 up 406.91 % up 406.91 % - -
Novaccess Global Inc 2Q 2024 - - - -
Xtl Biopharmaceuticals Ltd 4Q 2023 - - - -
Y mabs Therapeutics inc 2Q 2022 down-1.41 % up 2.97 % - -
Zenas Biopharma Inc 3Q 2024 - - - -
Zai Lab Limited 1Q 2023 up 34.4 % up 0.31 % - -
Zentalis Pharmaceuticals Inc 3Q 2022 - - - -
Zomedica Corp 3Q 2022 up 21113.47 % up 12.48 % - -
Zoetis Inc 3Q 2023 up 7.44 % down -1.33 % up 12.88 % down -11.04 %
Zevra Therapeutics Inc 3Q 2022 up 46.26 % up 121.08 % - -
Zyversa Therapeutics Inc 2Q 2024 - - - -
Zymeworks Inc 3Q 2024 down-3.07 % down -16.85 % - -
Zynerba Pharmaceuticals Inc 2Q 2021 - - - -
Revenue
Major Pharmaceutical Preparations Industry

recorded in the 4. Quarter 2024 above average Revenue growth of 7.17 % year on year, Total Ranking #86 and ranking within sector #6.

Sequentially Revenues for Major Pharmaceutical Preparations Industry grew by 31.86 %.

More on Major Pharmaceutical Preparations Industry Revenue Growth




Income
Major Pharmaceutical Preparations Industry
in the 4. Quarter 2024 recorded net loss, compared to net income realized in the same quarter a year ago.

Sequentially, Major Pharmaceutical Preparations Industry Net loss narrowed from previous quarter.

More on Major Pharmaceutical Preparations Industry Income Growth




• Inc. Cont. Ops.
• Net Income
• EPS Cont. Ops.
• EPS Net
• Free Cash Flow
• Net Cash Flow
• Capex






Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com